These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 8902789)
41. Differential expression of cyclooxygenase 2 in human colorectal cancer. Hull M; Langman M Gut; 2000 Jul; 47(1):154. PubMed ID: 10917748 [No Abstract] [Full Text] [Related]
42. [Expression of cyclooxygenase-2 in ovarian carcinoma and its significance]. Luo WZ; Shen J; Zhang Y; Lang JH Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1374-6. PubMed ID: 15637815 [No Abstract] [Full Text] [Related]
43. [Tissue microarray technique and its uses in study of relation between expression of cyclooxygenase in laryngeal neoplasms]. Dong P; Li XY; Zhu ZH; Yu ZW; Lu GZ; Zhu JC; Jin B Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(16):1371-3. PubMed ID: 15637814 [No Abstract] [Full Text] [Related]
44. Human lymphocytes stimulate prostacyclin synthesis in human umbilical vein endothelial cells. Involvement of endothelial cPLA2. Merhi-Soussi F; Dominguez Z; Macovschi O; Dubois M; Savany A; Lagarde M; Prigent AF J Leukoc Biol; 2000 Dec; 68(6):881-9. PubMed ID: 11129656 [TBL] [Abstract][Full Text] [Related]
45. Cyclooxygenase-2 expression in fibroblasts and endothelial cells of intestinal polyps. Sonoshita M; Takaku K; Oshima M; Sugihara K; Taketo MM Cancer Res; 2002 Dec; 62(23):6846-9. PubMed ID: 12460897 [TBL] [Abstract][Full Text] [Related]
46. Differential measurement of constitutive (COX-1) and inducible (COX-2) cyclooxygenase expression in human umbilical vein endothelial cells using specific immunometric enzyme immunoassays. Créminon C; Habib A; Maclouf J; Pradelles P; Grassi J; Frobert Y Biochim Biophys Acta; 1995 Feb; 1254(3):341-8. PubMed ID: 7857975 [TBL] [Abstract][Full Text] [Related]
47. Type-I 15-hydroxyprostaglandin dehydrogenase: role in macrophage/osteoclast differentiation. Pichaud F; Delage-Mourroux R; Frenkian M; Frendo JL; Roux S; de Vernejoul MC; Jullienne A Adv Exp Med Biol; 1997; 433():399-402. PubMed ID: 9561180 [No Abstract] [Full Text] [Related]
48. Cyclooxygenase-2 and atherosclerosis: friend or foe? Massy ZA; Swan SK Nephrol Dial Transplant; 2001 Dec; 16(12):2286-9. PubMed ID: 11733615 [No Abstract] [Full Text] [Related]
49. Glial and neuronal expression of cyclooxygenase-2: relevance to Alzheimer's disease. O'Banion MK; Chang JW; Kaplan MD; Yermakova A; Coleman PD Adv Exp Med Biol; 1997; 433():177-80. PubMed ID: 9561129 [No Abstract] [Full Text] [Related]
50. Molecular regulation and augmentation of prostacyclin biosynthesis. Wu KK Agents Actions Suppl; 1995; 45():11-7. PubMed ID: 7717168 [TBL] [Abstract][Full Text] [Related]
51. Neuronal prostacyclin receptors. Wise H Prog Drug Res; 1997; 49():123-54. PubMed ID: 9388386 [No Abstract] [Full Text] [Related]
52. The role of eicosanoids in the pathogenesis of hemolytic uremic syndrome. Benigni A; Remuzzi G Prostaglandins Leukot Essent Fatty Acids; 1994 Aug; 51(2):75-9. PubMed ID: 7972269 [No Abstract] [Full Text] [Related]
53. Do elevated levels of eicosanoids play a role in head and neck cancer recurrence and metastasis? Implications for prevention and treatment. Cherukuri DP; Nelson MA Cancer Biol Ther; 2004 Sep; 3(9):853-4. PubMed ID: 15467420 [No Abstract] [Full Text] [Related]
54. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Phipps RP; Kaufman J; Blumberg N Lancet; 2001 Jun; 357(9273):2023-4. PubMed ID: 11438137 [No Abstract] [Full Text] [Related]
55. On radiation damage to normal tissues and its treatment. II. Anti-inflammatory drugs. Michalowski AS Acta Oncol; 1994; 33(2):139-57. PubMed ID: 8204269 [TBL] [Abstract][Full Text] [Related]
56. Neuroinflammation in Alzheimer's disease: potential targets for disease-modifying drugs. Hüll M; Hampel H Ernst Schering Res Found Workshop; 2002; (39):159-78. PubMed ID: 12066411 [No Abstract] [Full Text] [Related]